← Open Payments lookup

KRISTEN JUBB: Open Payments

NPI 1598042848 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,090 in 98 payments from 19 companies in 2025. Trend: 2023 $823 · 2024 $2,465 · 2025 $2,090

Food & beverage: $1,986Education: $104
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP9$263
Novartis Pharmaceuticals Corporation9$207
Genentech USA, Inc.10$200
GlaxoSmithKline, LLC.10$200
GENZYME CORPORATION10$192
Lilly USA, LLC6$149
Amgen Inc.15$148
CSL Behring4$119
Regeneron Healthcare Solutions, Inc.5$113
ARS Pharmaceuticals Operations, Inc.5$99

Products named: DUPIXENT, Xolair, TEZSPIRE, NUCALA, AIRSUPRA, NEFFY, EBGLYSS, Rhapsido.

Industry payments across MD — which companies pay providers there.